Angelini Ventures, international venture capital company of Angelini Industries, has invested 6 million dollars in Cadence Neuroscience, an American start-up that is developing, in collaboration with researchers of the Mayo Clinic, a new neuro-therapymodulation for the treatment of drug-resistant fo...